by Jordana Choucair | Jan 19, 2023 | Health IT
A new Kaiser Family Foundation (KFF) analysis suggests that expanded use of telehealth services did not lead to significant cost savings early in the COVID-19 pandemic. According to the analysis, 52 percent of mental health therapy claims in 2020 for people with...
by Jordana Choucair | Jan 19, 2023 | Life Sciences
A new report from the Government Accountability Office found that the Department of Health and Human Services’ (HHS) process for monitoring high-risk research on viruses and other agents that can cause pandemics does not meet the standards for effective...
by Jordana Choucair | Jan 19, 2023 | Life Sciences
The National Institute of Allergy and Infectious Diseases reported that a Phase 3 clinical trial of Janssen’s HIV vaccine was stopped because the vaccine was ineffective. The trial began in 2019 and included 3,900 gay men and transgender people at over 50 sites in...
by Jordana Choucair | Jan 19, 2023 | Opioid/Substance Use Disorders
West Virginia State Attorney General Patrick Morrisey announced the state has agreed to an $83 million settlement with Walgreens Boots Alliance Inc. to resolve a lawsuit alleging that the company’s failed control measures contributed to an oversupply of opioids...
by Jordana Choucair | Jan 19, 2023 | Providers
KFF published a synthesis of recent studies on the economic impact of Medicaid expansion on providers. Thirty-nine states plus Washington D.C. have adopted Medicaid expansion under the Affordable Care Act (ACA), with the federal government covering 90 percent of the...
by Jordana Choucair | Jan 18, 2023 | Access & Coverage
Providers warn that the anticipated end of the COVID-19 public health emergency (PHE) will cause a “disruptive” and “abrupt return” to the old way of dispensing controlled substances. The PHE allowed physicians to prescribe controlled substances remotely. After the...
Recent Comments